Class I
Terminated
SYMJEPI (epinephrine injection, USP) 0.15 mg (0.15 mg/0.3 mL), Two Pre-Filled Single-Dose Syringes per carton, Rx Only, Manufactured for Adamis Pharmaceuticals Corp.; San Diego, CA 92130; Distributed by USWM, LLC., Louisville, KY 40241, Made in Belgium, NDC 78670-131-02.
This recall has been terminated (originally issued April 13, 2022).
- Recall Initiated
- March 21, 2022
- Posted
- April 13, 2022
- Recall Number
- D-0764-2022
- Voluntary / Mandated
- Voluntary: Firm initiated
- Quantity
- 2,500 cartons
- Firm Location
- San Diego, CA, United States
- Official Source
- View on FDA website ↗
Reason for Recall
Defective Delivery System: Potential clogging of the needle preventing the dispensing of epinephrine.
Distribution
Nationwide in the U.S.A.
Lot / Code Info
Lot # 21101Y, Exp. 11/30/2022
Other recent Class I Drug recalls
UDENYCA, pegfilgrastim-cbqv injection, 6 mg/0.6mL Single Dose Prefilled Syringe, Rx only, Manufactu...
Mckesson
· Feb 18, 2026
Green Lumber Natural Fuel For Men capsule, packaged in 2, 4, 10, and 30-count blister packs. GreenLu...
Green Lumber Holdings, Llc
· Feb 11, 2026
Rheumacare capsules, 30 count bottle, Mfg in India by: Virgo UAP Pharma Pvt. Ltd., Ahmedabad, India...
Handelnine Global Llc
· Feb 11, 2026
ClearLife Allergy Nasal Spray, Extra Strength, 0.68 fl. oz. (20 mL) bottles, Distributed by: MediNat...
Medinatura New Mexico, Inc.
· Jan 14, 2026
Famotidine Injection, USP, 20 mg per 2 mL (10 mg per mL), 2 mL vials, Rx only, Fresenius Kabi USA, L...
Fresenius Kabi Usa, Llc
· Dec 3, 2025